{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:49:13Z","timestamp":1791150553646,"version":"4.1.0"},"publisher-location":"Chichester, UK","update-to":[{"DOI":"10.1002\/14651858.cd005154.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000},"record-id":"33308"},{"DOI":"10.1002\/14651858.cd005154","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000},"record-id":"33309"}],"reference-count":39,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005154.pub3","type":"reference-entry","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T19:50:38Z","timestamp":1328903438000},"source":"Crossref","is-referenced-by-count":7,"title":["Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults"],"prefix":"10.1002","author":[{"given":"Anna","family":"Holdgate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeline","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,2,15]]},"reference":[{"issue":"Suppl 2","key":"10.1002\/14651858.CD005154.pub3-BIB1|cit1","first-page":"19","article-title":"Paroxysmal supraventricular tachycardia: efficacy of adenosine versus verapamil","volume":"42","author":"Cabrera-Sole","year":"1989","journal-title":"Revista Espanola de Cardiologia"},{"key":"10.1002\/14651858.CD005154.pub3-BIB2|cit2","first-page":"773","article-title":"A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia","volume":"42","author":"Cheng","year":"2003","journal-title":"Chinese Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD005154.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-113-2-104","article-title":"Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials","volume":"113","author":"DiMarco","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD005154.pub3-BIB4|cit4","first-page":"55","article-title":"Adenosin-three phosphate compared with verapamil to treat paroxysmal supraventricular tachycardia","volume":"66","author":"Ferreira","year":"1996","journal-title":"Arquivos Brasileros de Cardiologia"},{"key":"10.1002\/14651858.CD005154.pub3-BIB5|cit5","first-page":"55","article-title":"Adenosin triphosphate in the treatment of paroxysmal supraventricular tachycardia: a comparison with verapamil","volume":"48","author":"Gil Madre","year":"1995","journal-title":"Revista Espanola de Cardiologia"},{"key":"10.1002\/14651858.CD005154.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.66.3.504","article-title":"Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, adenosine-5'-triphosphate and verapamil: a comparative study","volume":"66","author":"Greco","year":"1982","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD005154.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/0002-8703(92)90807-8","article-title":"Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial","volume":"123","author":"Hood","year":"1992","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD005154.pub3-BIB8|cit8","first-page":"295","article-title":"Efficacy and safety of adenosine in termination of paroxysmal supraventricular tachycardia: comparison with verapamil.","volume":"49","author":"Kulakowski","year":"1998","journal-title":"Kardiologia Polska"},{"key":"10.1002\/14651858.CD005154.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.resuscitation.2009.01.017","article-title":"Slow infusion of calcium channel blcoers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia","volume":"80","author":"Lim","year":"2009","journal-title":"Resuscitation"},{"key":"10.1002\/14651858.CD005154.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.plefa.2006.03.005","article-title":"Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia","volume":"74","author":"Vranic","year":"2006","journal-title":"Prostaglandins, Leukotrienes and Essentail Fatty Acids"},{"key":"10.1002\/14651858.CD005154.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ehj.2004.05.011","article-title":"Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia","volume":"25","author":"Ballo","year":"2004","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD005154.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0002-9149(84)90334-5","article-title":"Acute management of supraventricular tachycardia: verapamil, adenosine triphosphate or adenosine?","volume":"54","author":"Belhassen","year":"1984","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD005154.pub3-BIB13|cit13","first-page":"499","article-title":"Adenosine triphosphate and the treatment of paroxysmal supraventricular tachycardia: a comparison with verapamil","volume":"48","author":"Conti Gimenez","year":"1995","journal-title":"Revista Espanola de Cardiologia"},{"key":"10.1002\/14651858.CD005154.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/0002-9149(89)90573-0","article-title":"Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia","volume":"64","author":"Garratt","year":"1989","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD005154.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-114-6-513","article-title":"Adenosine or verapamil for the acute treatment of supraventricular tachycardia?","volume":"114","author":"Rankin","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD005154.pub3-BIB16|cit16","first-page":"283","article-title":"Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias","volume":"230","author":"Sellers","year":"1987","journal-title":"Progress in Clinical and Biological Research"},{"key":"10.1002\/14651858.CD005154.pub3-BIB17|cit17","first-page":"141","article-title":"Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia","volume":"46","author":"Sethi","year":"1994","journal-title":"Indian Heart Journal"},{"key":"10.1002\/14651858.CD005154.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s003900050072","article-title":"Acute management of supraventricular tachycardia: adenosine or ajmaline?","volume":"34","author":"Trappe","year":"1997","journal-title":"Intensivmedizin und Notfallmedizin"},{"key":"10.1002\/14651858.CD005154.pub3-BIB19|cit19","first-page":"452","article-title":"Effect of adenosine in termination of induced supraventricular tachycardias and comparison with verapamil","volume":"24","author":"Turkoglu","year":"1996","journal-title":"Turk Kardiyoloji Dernegi Arsivi"},{"issue":"24 Suppl","key":"10.1002\/14651858.CD005154.pub3-BIB20|cit20","first-page":"IV67 - IV77","article-title":"Management of symptomatic bradycardia and tachycardia","volume":"112","year":"2005","journal-title":"Circulation"},{"issue":"24 Suppl","key":"10.1002\/14651858.CD005154.pub3-BIB21|cit21","first-page":"IV167","article-title":"Pediatric Advanced Life Support","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD005154.pub3-BIB22|cit22","first-page":"169","article-title":"Disturbances of cardiac rhythm and conduction","volume-title":"Emergency Medicine - a comprehensive study guide","author":"Bolton","year":"2000"},{"key":"10.1002\/14651858.CD005154.pub3-BIB23|cit23","first-page":"162","article-title":"Arrhythmias","volume-title":"Textbook of adult emergency medicine","author":"Meyer","year":"2000"},{"key":"10.1002\/14651858.CD005154.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005154.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0002-9149(92)90196-6","article-title":"Acute conversion of paroxysmal supraventricular tachycardia. IV diltiazem study group","volume":"70","author":"Dougherty","year":"1992","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD005154.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2165\/00003495-199141040-00007","article-title":"Adenosine. An evaluation of its use in diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.","volume":"41","author":"Faulds","year":"1991","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD005154.pub3-BIB27|cit27","first-page":"969","article-title":"Comparison of the efficacy of diltiazem and esmolol in terminating supraventricular tachycardia","volume":"47","author":"Gupta","year":"1999","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1002\/14651858.CD005154.pub3-BIB28|cit28","article-title":"The tachyarrhythmias","volume-title":"Harrisons Textbook of Internal Medicine","author":"Josephson","year":"2003"},{"key":"10.1002\/14651858.CD005154.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1442-2026.2001.00178.x","article-title":"Randomized controlled trial of midazolam premedication to reduce the subjective adverse effects of adenosine","volume":"13","author":"Hourigan","year":"2001","journal-title":"Emergency Medicine Australasia"},{"key":"10.1002\/14651858.CD005154.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9149(91)90706-Q","article-title":"Efficacy and safety of intravenous sotalol for termination of supraventricular tachycardia. The sotalol versus placebo multicenter study group","volume":"68","author":"Jordaens","year":"1991","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD005154.pub3-BIB31|cit31","first-page":"529","article-title":"Efficacy of intravenous magnesium suplphate in supraventricular tachyarrhythmias","volume":"43","author":"Joshi","year":"1995","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1002\/14651858.CD005154.pub3-BIB32|cit32","article-title":"Agents used in cardiac arrhythmias","volume-title":"Basic and Clinical Pharmacology","author":"Hondeghem","year":"1995"},{"key":"10.1002\/14651858.CD005154.pub3-BIB33|cit33","series-title":"Fourth International Cochrane Colloquium, Adelaide, Australia, 20-24 October","article-title":"Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE","author":"Lefebvre","year":"1996"},{"key":"10.1002\/14651858.CD005154.pub3-BIB34|cit34","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009)"},{"key":"10.1002\/14651858.CD005154.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0196-0644(98)70277-X","article-title":"Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage","volume":"31","author":"Lim","year":"1998","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD005154.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the Quorom statement","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005154.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0735-6757(88)90090-3","article-title":"Treatment of paroxysmal supraventricular tachycardia in the emergency department by clinical decision analysis","volume":"6","author":"Ornato","year":"1990","journal-title":"American Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD005154.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1742-6723.2004.00628.x","article-title":"Incorrect instruction in the use of the Valsalva manoeuvre for paroxysmal supaventricular tachycardia is common","volume":"16","author":"Taylor","year":"2004","journal-title":"Emergency Medicine Australasia"},{"key":"10.1002\/14651858.CD005154.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/01.CIR.98.24.2716","article-title":"Electrophysiological mechanisms and determinants of vagal manouevres for termination of paroxysmal supraventricular tachycardia","volume":"98","author":"Wen","year":"1998","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005154.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005154.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:45:38Z","timestamp":1628545538000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005154.pub3"}},"subtitle":[],"editor":[{"given":"Anna","family":"Holdgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,15]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005154.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD005154.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,2,15]]}}}